6.07
price up icon4.66%   0.27
after-market Handel nachbörslich: 6.07
loading

Karyopharm Therapeutics Inc Aktie (KPTI) Neueste Nachrichten

pulisher
04:05 AM

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - WV News

04:05 AM
pulisher
02:20 AM

Karyopharm (KPTI) Reports Strong Q3 2025, Highlights Myelofibros - GuruFocus

02:20 AM
pulisher
02:06 AM

Karyopharm Therapeutics Inc. Reaffirms Earnings Guidance for the Full Year 2025 - MarketScreener

02:06 AM
pulisher
01:21 AM

Transcript : Karyopharm Therapeutics Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener

01:21 AM
pulisher
01:13 AM

Karyopharm Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat

01:13 AM
pulisher
01:06 AM

Karyopharm Therapeutics: Q3 Earnings Snapshot - CTPost

01:06 AM
pulisher
10:48 AM

Karyopharm Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView

10:48 AM
pulisher
09:46 AM

Earnings call transcript: Karyopharm Q3 2025 shows revenue growth, pre-market dip - Investing.com

09:46 AM
pulisher
09:00 AM

How geopolitical tensions affect Karyopharm Therapeutics Inc. stock2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - newser.com

09:00 AM
pulisher
08:57 AM

Karyopharm Grows Revenue With Strong XPOVIO Sales And Partnerships - Finimize

08:57 AM
pulisher
08:41 AM

Is Karyopharm Therapeutics Inc. (25K0) stock a top hedge fund pickIPO Watch & Safe Capital Growth Trade Ideas - newser.com

08:41 AM
pulisher
08:23 AM

Analyzing net buyer seller activity in Karyopharm Therapeutics Inc.July 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com

08:23 AM
pulisher
07:42 AM

Karyopharm (KPTI) Surpasses Q3 Revenue Expectations with Clinica - GuruFocus

07:42 AM
pulisher
07:42 AM

Karyopharm (KPTI) Projects Revenue Growth and Expense Reduction for FY25 - GuruFocus

07:42 AM
pulisher
07:23 AM

Karyopharm Therapeutics Inc. SEC 10-Q Report - TradingView

07:23 AM
pulisher
07:11 AM

Karyopharm Therapeutics' Q3 net loss widens - TradingView

07:11 AM
pulisher
07:00 AM

Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress - PR Newswire

07:00 AM
pulisher
06:09 AM

How Karyopharm Therapeutics Inc. (25K0) stock reacts to new regulationsQuarterly Market Review & Verified Technical Trade Signals - newser.com

06:09 AM
pulisher
05:50 AM

Quantitative breakdown of Karyopharm Therapeutics Inc. recent moveWeekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com

05:50 AM
pulisher
05:14 AM

Karyopharm Therapeutics Inc. stock trend outlook and recovery path2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com

05:14 AM
pulisher
01:08 AM

Is it time to cut losses on Karyopharm Therapeutics Inc.July 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com

01:08 AM
pulisher
Nov 02, 2025

Using Ichimoku Cloud for Karyopharm Therapeutics Inc. technicalsQuarterly Earnings Report & Free Fast Gain Swing Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Karyopharm Therapeutics Inc. (25K0) stock cheap vs fundamentalsMarket Performance Summary & Fast Entry High Yield Stock Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Karyopharm Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Drop Watch & Growth Focused Stock Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can Karyopharm Therapeutics Inc. stock continue upward trend2025 Market Sentiment & Daily Stock Trend Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What makes Karyopharm Therapeutics Inc. (25K0) stock appealing to growth investors2025 Technical Overview & Reliable Volume Spike Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Karyopharm Therapeutics Inc. stock safe for conservative investorsPortfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Is Karyopharm Therapeutics Inc. stock vulnerable to regulatory risksWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Karyopharm Therapeutics Inc expected to post a loss of $3.13 a shareEarnings Preview - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Earnings To Watch: Karyopharm Therapeutics Inc (KPTI) Reports Q3 2025 Result - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Technical signs of recovery in Karyopharm Therapeutics Inc.2025 Technical Overview & Safe Entry Trade Signal Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Regression analysis insights on Karyopharm Therapeutics Inc. performance2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 05:27:00 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can Karyopharm Therapeutics Inc. (25K0) stock sustain revenue momentumQuarterly Performance Summary & Daily Chart Pattern Signals - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Karyopharm Therapeutics (KPTI) Price Target Decreased by 10.98% to 15.98 - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

Karyopharm Therapeutics (NASDAQ:KPTI) Shares Pass Above 50-Day Moving AverageHere's What Happened - MarketBeat

Oct 30, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):